LH Labcorp
- Official Name: LABCORP HOLDINGS INC.
- Headquarters: 358 S Main St, BURLINGTON, NC, 27215 US
- CEO: Adam Schechter
- Website: labcorp.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Lost by 5.737 | (4.665) - 1.072 | ||
| 2025-07-22 | 2 | Won by 1.743 | 2.727 - 0.984 | ||
| 2025-07-29 | 3 | Won by 4.460 TOTW | 6.702 - 2.242 | ||
| 2025-07-29 | 2R | Lost by 0.413 | (0.396) - 0.017 | ||
| 2025-08-05 | 4 | Won by 7.168 | 1.486 - (5.682) | ||
| 2025-08-06 | 1R | Lost by 1.938 | (0.984) - 0.954 | ||
| 2025-08-07 | 1R | Lost by 2.347 | (0.652) - 1.695 | ||
| 2025-08-12 | 5 | Won by 1.176 | 2.085 - 0.909 | ||
| 2025-08-19 | 6 | Won by 8.220 | 4.612 - (3.608) | ||
| 2025-08-26 | 7 | Lost by 2.991 | 1.009 - 4.000 | ||
| 2025-09-02 | 8 | Lost by 1.116 | (2.123) - (1.007) | ||
| 2025-09-09 | 9 | Won by 0.231 | 1.715 - 1.484 | ||
| 2025-09-16 | 10 | Lost by 1.700 | (1.528) - 0.172 | ||
| 2025-09-23 | 11 | Won by 1.297 | 2.011 - 0.714 | ||
| 2025-09-30 | 12 | Won by 4.311 | 2.739 - (1.572) | ||
| 2025-10-07 | 13 | Lost by 0.341 | (2.158) - (1.817) | ||
| 2025-10-14 | 14 | Lost by 0.765 | 0.056 - 0.821 | ||
| 2025-10-21 | 15 | Won by 1.279 | 1.542 - 0.263 |
Latest News

OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
OPK's $722M BioReference asset sale to Labcorp, with a potential $150M earnout, aims to sharpen its biopharma focus and expand access to the 4Ksc...

PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?
PACS Group, Inc. (PACS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate ...

Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook
Labcorp Holdings has delivered a strong share price run in recent years, so the key issue now is whether the current US$325.07 level is properly suppo...

Sector Update: Healthcare Stocks Gain Thursday Afternoon
Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index rising 2.3% and the State

Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and i...

Opko Health stock soars on $722M BioReference asset sale
Investing.com -- Opko Health Inc (NASDAQ:OPK) shares surged 20% in premarket trading Thursday after Labcorp Holdings Inc (NYSE:LH) agreed to acquire s...

OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal
OPKO Health jumps 18% and Labcorp trades higher as LH acquires BioReference Health assets in an $872M deal.

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharm...
UPDATE: Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biophar...
Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biophar...

Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?
ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation be...

Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Thrive 5 Health Test, the f...

Should You Trim Or Add To Your Hims & Hers Position Now?
Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17...

Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?
Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, h...